In androgen-independent, apoptosis-resistant prostate cancer cells, such remodeling was shown to involve reduced SOCE via downregulation of Orai1 or Stim1 proteins, and adaptation of the ER to the conditions of reduced Ca2+ storage and uptake [18,44]. The gene discussed is ORAI1; the disease is prostate cancer.